Samsung Biologics Exec Jo Seong-hwan Withdraws 50 Shares from ESOP
- Samsung Biologics Managing Director Jo Seong-hwan (non-registered executive) withdrew 50 common shares from the employee stock ownership account to his personal account
- Post-withdrawal holding is 50 shares (0.00%), negligible relative to total outstanding shares of 46,290,951
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
- Company: Samsung Biologics (207940)
- Submission: Jo Seong-hwan
- Receipt: 05-20-2026